{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:28:27Z","timestamp":1784302107307,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0734-3","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T07:37:52Z","timestamp":1448955472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lack of integrase inhibitors associated resistance mutations among HIV-1C isolates"],"prefix":"10.1186","volume":"13","author":[{"given":"Andargachew","family":"Mulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe Gerd","family":"Liebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"734_CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jmb.2008.10.071","volume":"385","author":"SG Sarafianos","year":"2009","unstructured":"Sarafianos SG, Marchand B, Das K, Himmel DM, Parniak MA, Hughes SH, et al. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol. 2009;385:693\u2013713.","journal-title":"J Mol Biol"},{"key":"734_CR2","doi-asserted-by":"crossref","first-page":"40858","DOI":"10.1074\/jbc.R112.397760","volume":"287","author":"A Engelman","year":"2012","unstructured":"Engelman A, Krishnan L. Retroviral integrase proteins and HIV-1 DNA integration. J Biol Chem. 2012;287:40858\u201366. doi: 10.1074\/jbc.R112.397760 .","journal-title":"J Biol Chem"},{"key":"734_CR3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tibs.2005.12.002","volume":"31","author":"B Maele Van","year":"2006","unstructured":"Van Maele B, Busschots K, Vandekerckhove L, Christ F, Debyser Z. Cellular co-factors of HIV-1 integration. Trends Biochem Sci. 2006;31:98\u2013105.","journal-title":"Trends Biochem Sci"},{"key":"734_CR4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2174\/1568026043388547","volume":"4","author":"TK Chiu","year":"2004","unstructured":"Chiu TK, Davies DR. Structure and function of HIV-1 integrase. Curr Top Med Chem. 2004;4:965\u201377.","journal-title":"Curr Top Med Chem"},{"key":"734_CR5","doi-asserted-by":"crossref","first-page":"23213","DOI":"10.1074\/jbc.R100027200","volume":"276","author":"R Craigie","year":"2000","unstructured":"Craigie R. HIV integrase, a brief overview from chemistry to therapeutics. J Biol Chem. 2000;276:23213\u20136.","journal-title":"J Biol Chem"},{"key":"734_CR6","first-page":"26","volume":"7","author":"B Maele Van","year":"2005","unstructured":"Van Maele B, Debyser Z. HIV-1 integration: an-interplay between HIV-1 integrase, cellular and viral proteins. AIDS Rev. 2005;7:26\u201343.","journal-title":"AIDS Rev"},{"key":"734_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa0708978","volume":"359","author":"DA Cooper","year":"2008","unstructured":"Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, Yeni P, et al. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. N Engl J Med. 2008;359:355\u201365.","journal-title":"N Engl J Med"},{"key":"734_CR8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/135965350801300710","volume":"13","author":"MJ Buz\u00f3n","year":"2008","unstructured":"Buz\u00f3n MJ, Marfil S, Puertas MC, Garcia E, Clotet B, Ruiz L, et al. Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. Antivir Ther. 2008;13:881\u201393.","journal-title":"Antivir Ther"},{"key":"734_CR9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e3283367796","volume":"24","author":"C Charpentier","year":"2010","unstructured":"Charpentier C, Laureillard D, Piketty C, Tisserand P, Batisse D, Karmochkine M, et al. High frequency of integrase Q148R minority variants in HIV-infected patient\u2019s naive of integrase inhibitors. AIDS. 2010;24:867\u201373.","journal-title":"AIDS"},{"key":"734_CR10","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1128\/JVI.00894-09","volume":"83","author":"R Quercia","year":"2009","unstructured":"Quercia R, Dam E, Perez-Bercoff D, Clavel F. Selective advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes. J Virol. 2009;83:10245\u20139.","journal-title":"J Virol"},{"key":"734_CR11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/QAD.0b013e32833cf265","volume":"24","author":"T Bar-Magen","year":"2010","unstructured":"Bar-Magen T, Donahue DA, McDonough EI, Kuhl BD, Faltenbacher VH, Xu H, et al. HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays. AIDS. 2010;24:2171\u20139.","journal-title":"AIDS."},{"key":"734_CR12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/aid.2009.0249","volume":"26","author":"MQ Fish","year":"2010","unstructured":"Fish MQ, Hewer R, Wallis CL, Venter WD, Stevens WS, Papathanasopoulos MA. Natural polymorphisms of integrase among HIV type 1-infected South African patients. AIDS Res Hum Retrovir. 2010;26:489\u201393. doi: 10.1089\/aid.2009.0249 .","journal-title":"AIDS Res Hum Retrovir"},{"key":"734_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/aid.2009.0281","volume":"26","author":"MA Papathanasopoulos","year":"2010","unstructured":"Papathanasopoulos MA, Vardas E, Wallis C, Glashoff R, Butt\u00f3 S, Poli G, et al. Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS vaccine integrated project (AVIP) study. AIDS Res Hum Retrovir. 2010;26:705\u20139. doi: 10.1089\/aid.2009.0281 .","journal-title":"AIDS Res Hum Retrovir"},{"key":"734_CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/QAD.0b013e32832ac34e","volume":"23","author":"MC Hosseinipour","year":"2009","unstructured":"Hosseinipour MC, van Oosterhout JJ, Weigel R, Phiri S, Kamwendo D, Parkin N, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS. 2009;23:1127\u201334.","journal-title":"AIDS"},{"key":"734_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAI.0b013e318227fc34","volume":"58","author":"KC Sigaloff","year":"2011","unstructured":"Sigaloff KC, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, et al. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. J Acquir Immune Defic Syndr. 2011;58:23\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"734_CR16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/QAI.0b013e3181bc478b","volume":"53","author":"CL Wallis","year":"2010","unstructured":"Wallis CL, Mellors JW, Venter WD, Sanne I, Stevens W. Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr. 2010;53:480\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"734_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/599611","volume":"49","author":"D Koyalta","year":"2009","unstructured":"Koyalta D, Charpentier C, Beassamda J, Rey E, Si-Mohamed A, Djemadji-Oudjeil N, et al. High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N\u2019Djamena, Chad. Clin Infect Dis. 2009;49:155\u20139.","journal-title":"Clin Infect Dis"},{"key":"734_CR18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1086\/587109","volume":"46","author":"VC Marconi","year":"2008","unstructured":"Marconi VC, Sunpath H, Lu Z, Gordon M, Koranteng-Apeagyei K, Hampton J, et al. Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in Kwa Zulu Natal, South Africa. Clin Infect Dis. 2008;46:1589\u201397.","journal-title":"Clin Infect Dis"},{"key":"734_CR19","author":"Mulu","year":"2014","unstructured":"Mulu, Lange T, Liebert UG, Maier M. Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia. BMC Infect Dis. 2014;. doi: 10.1186\/1471-2334-14-158 .","journal-title":"BMC Infect Dis."},{"issue":"6","key":"734_CR20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jmv.24110","volume":"87","author":"K Huruy","year":"2015","unstructured":"Huruy K, Maier M, Mulu A, Liebert UG. Limited increase in primary HIV-1C drug resistance mutations in treatment na\u00efve individuals in Ethiopia. J Med Virol. 2015;87(6):978\u201384. doi: 10.1002\/jmv.24110 .","journal-title":"J Med Virol"},{"issue":"10","key":"734_CR21","doi-asserted-by":"crossref","first-page":"e0141318","DOI":"10.1371\/journal.pone.0141318","volume":"10","author":"A Mulu","year":"2015","unstructured":"Mulu A, Maier M, Liebert UG. Low incidence of HIV-1C acquired drug resistance 10\u00a0years after roll-out of antiretroviral therapy in Ethiopia: a prospective cohort study. PLoS One. 2015;10(10):e0141318. doi: 10.1371\/journal.pone.0141318 .","journal-title":"PLoS One"},{"key":"734_CR22","unstructured":"Wensing AM, Calvez V, G\u00fcnthard HF, Johnson VA, Paredes R, Pillay D, et al. Update of the drug resistance mutations in HIV-1: international AIDS society-USA. Top Antivir Med. 2015; 23(4) (Epub ahead of print)."},{"key":"734_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4690-5-7","volume":"5","author":"SY Rhee","year":"2008","unstructured":"Rhee SY, Liu TF, Kiuchi M, Zioni R, Gifford RJ, Holmes SP, et al. Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors. Retrovirology. 2008;5:7. doi: 10.1186\/1742-4690-5-74 .","journal-title":"Retrovirology"},{"key":"734_CR24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0708975","volume":"359","author":"RT Steigbigel","year":"2008","unstructured":"Steigbigel RT, Cooper DA, Kumar PN, Eron JE, Schechter M, Markowitz M, et al. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med. 2008;359:339\u201354.","journal-title":"N Engl J Med"},{"key":"734_CR25","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1089\/aid.2012.0058","volume":"28","author":"MF Oliveira","year":"2012","unstructured":"Oliveira MF, Ramalho DB, Abreu CM, Vubil A, Mabunda N, Ismael N, et al. Genetic diversity and naturally polymorphisms in HIV type 1 integrase isolates from Maputo, Mozambique: implications for integrase inhibitors. AIDS Res Hum Retrovir. 2012;28:1788\u201392. doi: 10.1089\/aid.2012.0058 .","journal-title":"AIDS Res Hum Retrovir"},{"key":"734_CR26","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1089\/aid.2011.0266","volume":"28","author":"O Turriziani","year":"2012","unstructured":"Turriziani O, Montagna C, Falasca F. Analysis of the integrase gene from hiv-1 positive patients living in a rural area of west Cameroon. AIDS Res Hum Retrovir. 2012;28:1729\u201333. doi: 10.1089\/AID.2011.0266 .","journal-title":"AIDS Res Hum Retrovir"},{"key":"734_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/QAI.0b013e31819df3b3","volume":"51","author":"CB Passaes","year":"2000","unstructured":"Passaes CB, Guimar\u00e3es ML, Fernandez SL, Lorete Rdos S, Teixeira SL, Fernandez JC, et al. Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil. J Acquir Immune Defic Syndr. 2000;51:7\u201312.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"734_CR28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jmv.22047","volume":"83","author":"BG Brenner","year":"2011","unstructured":"Brenner BG, Lowe M, Moisi D, Hardy I, Gagnon S, Charest H, et al. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors. J Med Virol. 2011;83:751\u20139.","journal-title":"J Med Virol"},{"key":"734_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/aid.2008.0236","volume":"25","author":"SH Eshleman","year":"2009","unstructured":"Eshleman SH, Hudelson SE, Smith P, Hackett J, Holzmayer V, Swanson P, et al. Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. AIDS Res Hum Retrovir. 2009;25:343\u20135. doi: 10.1089\/aid.2008.0236 .","journal-title":"AIDS Res Hum Retrovir"},{"key":"734_CR30","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1089\/08892220050195865","volume":"16","author":"A Abebe","year":"2000","unstructured":"Abebe A, Pollakis G, Fontanet AL, Fisseha B, Tegbaru B, Kliphuis A, et al. Identification of a genetic subcluster of HIV type 1 subtype C (C\u2019) widespread in Ethiopia. AIDS Res Hum Retrovir. 2000;16:1909\u201314.","journal-title":"AIDS Res Hum Retrovir"},{"key":"734_CR31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/088922203322588350","volume":"19","author":"G Pollakis","year":"2003","unstructured":"Pollakis G, Abebe A, Kliphuis A, De Wit TF, Fisseha B, Tegbaru B, et al. Recombination of HIV type 1C (C\u2019\/C) in Ethiopia: possible link of EthHIV-1C\u2019 to subtype C sequences from the high-prevalence epidemics in India and Southern Africa. AIDS Res Hum Retrovir. 2003;19:999\u20131008.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"28","key":"734_CR32","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1371\/journal.pone.0000730","volume":"15","author":"EA Soares","year":"2007","unstructured":"Soares EA, Santos AF, Sousa TM, Sprinz E, Martinez AM, Silveira J, et al. Differential drug resistance acquisition in HIV-1 of subtypes B and C. PLoS One. 2007;15(28):730.","journal-title":"PLoS One."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0734-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T22:37:15Z","timestamp":1653691035000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0734-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"377"}}